ABSTRACT
Telemedicine has the potential to transform the future of medicine in both rural and urban settings by improving access to medical care and providing a more affordable way to deliver it. Low reimbursement rates and lack of interstate licensing are the main obstacles limiting its widespread use in the United States. Demand for telemedicine, however, will likely continue to rise, and primary care providers will need to be familiar with the practical and legal considerations in establishing this type of service.
Footnotes
Dr. Rasmussen has disclosed consulting for Boston Scientific; membership on advisory committees or review panels for Boston Scientific, Medtronic, Mehana Medical, Nervive, Perflow Medical, and Stryker Neurovascular; and ownership interest (stock or stock options) in Nervive, Neurvana, and Perflow Medical.
- Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.
- Jamal H. Mahar, MD⇑
- Clinical Associate Staff, Medicine Institute, Cleveland Clinic
- Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
- ADDRESS:
Jamal H. Mahar, MD, Medicine Institute, M75, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; maharj{at}ccf.org
- Peter A. Rasmussen, MD
ABSTRACT
Telemedicine has the potential to transform the future of medicine in both rural and urban settings by improving access to medical care and providing a more affordable way to deliver it. Low reimbursement rates and lack of interstate licensing are the main obstacles limiting its widespread use in the United States. Demand for telemedicine, however, will likely continue to rise, and primary care providers will need to be familiar with the practical and legal considerations in establishing this type of service.
Footnotes
Dr. Rasmussen has disclosed consulting for Boston Scientific; membership on advisory committees or review panels for Boston Scientific, Medtronic, Mehana Medical, Nervive, Perflow Medical, and Stryker Neurovascular; and ownership interest (stock or stock options) in Nervive, Neurvana, and Perflow Medical.
- Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.
Commentary